Harashima, N., Takenaga, K., Akimoto, M., & Harada, M. (2017). HIF-2α dictates the susceptibility of pancreatic cancer cells to TRAIL by regulating survivin expression. Oncotarget.
Chicago Style CitationHarashima, Nanae, Keizo Takenaga, Miho Akimoto, i Mamoru Harada. "HIF-2α Dictates the Susceptibility of Pancreatic Cancer Cells to TRAIL By Regulating Survivin Expression." Oncotarget 2017.
Cita MLAHarashima, Nanae, Keizo Takenaga, Miho Akimoto, i Mamoru Harada. "HIF-2α Dictates the Susceptibility of Pancreatic Cancer Cells to TRAIL By Regulating Survivin Expression." Oncotarget 2017.
Atenció: Aquestes cites poden no estar 100% correctes.